Vivos Therapeutics VVOS
NASDAQ VVOS
$0.28 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) Prepaid Assets (2019 - 2026)

Vivos Therapeutics (VVOS) posted quarterly Prepaid Assets of $940000.0 for Q1 2026, up 71.85% year-over-year from $547000.0 in Q1 2025, and up 21.45% quarter-over-quarter from $774000.0 in Q4 2025.

Vivos Therapeutics (VVOS) Prepaid Assets (2019 - 2026) Analysis & Trends

Vivos Therapeutics (VVOS) has reported Prepaid Assets for 8 consecutive years, with $940000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets rose 71.85% year-over-year to $940000.0; the TTM figure through Mar 2026 stood at $940000.0 (up 71.85% YoY), while the FY2025 annual figure was $774000.0, down 1.15% from the prior year.
  • Prepaid Assets improved to $940000.0 in Q1 2026 per VVOS's latest filing, from $774000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.3 million in Q1 2022 and bottomed at $475000.0 in Q1 2024.
  • Historically, Prepaid Assets has averaged $1.0 million across 5 years, with a median of $774000.0 in 2025.
  • Annual changes were most pronounced in 2022 — Prepaid Assets jumped 143.09% — and 2024, when it tumbled 64.71%.
  • Vivos Therapeutics' Prepaid Assets stood at $1.4 million in 2022, then sank by 57.46% to $616000.0 in 2023, then rose by 27.11% to $783000.0 in 2024, then slipped by 1.15% to $774000.0 in 2025, then rose by 21.45% to $940000.0 in 2026.
  • Business Quant data shows VVOS's Prepaid Assets at $940000.0 in Q1 2026, $774000.0 in Q4 2025, and $565000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Vivos Therapeutics 4.94 Mn 3.14 Mn 2.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 940,000.00
Dec 31, 2025 774,000.00
Sep 30, 2025 565,000.00
Jun 30, 2025 695,000.00
Mar 31, 2025 547,000.00
Dec 31, 2024 783,000.00
Sep 30, 2024 634,000.00
Jun 30, 2024 554,000.00
Mar 31, 2024 475,000.00
Dec 31, 2023 616,000.00
Sep 30, 2023 769,000.00
Jun 30, 2023 1.07 Mn
Mar 31, 2023 1.35 Mn
Dec 31, 2022 1.45 Mn
Sep 30, 2022 2.12 Mn
Jun 30, 2022 2.06 Mn
Mar 31, 2022 2.26 Mn
Dec 31, 2021 1.58 Mn
Sep 30, 2021 1.60 Mn
Jun 30, 2021 1.67 Mn